Background Hearing loss is the third leading global cause of disability and is associated with poorer quality of life. Hearing aids are often recommended for hearing loss; however, hearing aid uptake and use rates are perpetually low. Motivational interviewing (MI) is a patient-centered counseling aimed at addressing the desire in the patient to change their behavior. The aim of this study is to investigate the impact of one-on-one MI sessions on hearing aid use among new adult users. Methods A multi-center, prospective, randomized patient-blind controlled trial with a pre- and post-tests design. New hearing aid users ≥ 18 years of age will be recruited from Vancouver, Canada. They will be randomly assigned to a treatment or control group. The treatment group will attend a one-on-one MI session hosted by a practicing MI therapist in addition to standard in-person audiological care. The control group will receive standard in-person audiological care. Data is collected at baseline and at 1, 3, 6, and 12 months’ follow-ups. The primary outcomes are data-logged hearing aid use hours and patient-reported outcomes as measured by the International Outcome Inventory for Hearing Aids questionnaire. Associations between intervention and hearing aid use hours and self-reported outcome measures will be assessed. Discussion This trial is designed to evaluate the efficacy of one-on-one MI in improving hearing aid use in new adult users in the short and long terms. Results will contribute to the evidence on whether MI counseling has an effect on hearing aid use and may guide future clinical practices. Trial registration ClinicalTrials.gov NCT04673565. Registered on 17 December 2020.
• Background: : Hearing loss is the third leading global cause of disability and is associated with poorer quality of life. Hearing aids are often recommended for hearing loss; however, hearing aid uptake and use rates are perpetually low. Motivational interviewing (MI) is a patient-centered counselling aimed at addressing desire in the patient to change their behaviour. The aim of this study is to investigate the impact of one-on-one MI sessions on hearing aid use among new adult users • Methods: A multi-center, prospective, randomized patient-blind controlled trial with a pre- and post- tests design. New hearing aid users ≥ 18 years of age will be recruited from Vancouver, Canada. They will be randomly assigned to a treatment or control group. The treatment group will attend a one-on-one MI session hosted by a practicing MI therapist in addition to standard in-person audiological care. The control group will receive standard in-person audiological care. Data is collected at baseline and at 1, 3, 6, and 12 months follow-ups. The primary outcomes are data-logged hearing aid use hours and patient reported outcomes as measured by the International Outcome Inventory for Hearing Aids questionnaire. Associations between intervention and hearing aid use hours, and self-reported outcome measures will be assessed. • Discussion: This trial is designed to evaluate the efficacy of one-on-one MI in improving hearing aid use in new adult users in the short- and long- terms. Results will contribute to the evidence on whether MI counselling has an effect on hearing aid use and may guide future clinical practices.. • Trial registration: ClinicalTrials.gov. Review Board NCT04673565. Approved: December 17, 2020. https://clinicaltrials.gov/ct2/show/NCT04673565?cond=motivational+interviewing&cntry=CA&draw=2&rank=8
Background The pathogenesis of Sudden Sensorineural Hearing Loss is complex, and the prognosis for recovery is variable. While the pathological lesion is thought to be localized to the cochlea, recent microRNA findings suggest a primarily neuro-topic pathogenesis at least in some patients. This study seeks to use established hearing-loss categorization systems to distinguish neural from non-neural hearing loss patients and determine if the two groups differ in functional recovery. Methods The Charts of 132 Sudden Sensorineural Hearing Loss patients presenting at Vancouver General Hospital (November 2013-June 2019) were retrospectively reviewed. Patients’ characteristics, treatment modality, Pure Tone Audiometric thresholds (averaged across four frequencies: 0.5, 1, 2, and 3 kHz), and Word Recognition Scores were collected. Neural type Sudden Sensorineural Hearing Loss was defined as a presenting Word Recognition Score (<60%), with a Word Recognition Score reduction 20% greater than expected based on the averaged pure tone audiometric loss. Hearing recovery was defined as an improvement of ≥ 10 decibels in pure tone audiometric thresholds. Results 48 patients meeting the American Academy of Otolaryngology Head and Neck Surgery 2019 diagnostic criteria and with comprehensive data were included. 12 (mean age ± standard deviation: 57.7±14.9 years) and 36 (55.3±15.2 years) patients were classified as neural and sensory Sudden Sensorineural Hearing Loss, respectively. 66.7% (8/12) and (24/36) of neural and non-neural Sudden Sensorineural hearing loss patients, respectively demonstrated hearing recovery. The affected ear’s initial Word Recognition Score (mean ± standard deviation %): 17.1±17.6 and 71.5±35.5 (p < 0.0001), and Word Recognition Score change with treatment: 46.9±29.8 and 3.2±25.8 (p < 0.0001), in neural and non-neural patients, respectively were significantly different. Conclusion The hearing recovery rate in neural and sensory type Sudden Sensorineural Hearing Loss patients was similar. Patients with a neural type of hearing loss demonstrated greater word recognition score recovery after treatment than those in the sensory group.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.